Immunai Stock
HealthTechLooking to sell Immunai stock or options?
Immunai is a bioinformatics platform focused on improving our comprehension of complex diseases to facilitate the development of targeted therapies. The company's platform leverages artificial intelligence to analyze vast biological datasets and forecast treatment outcomes, empowering healthcare researchers to streamline drug discovery and development processes.
Investors Include:
Meron Capital, Endless Frontier Labs, 8VC, Alexandria Venture Investments, Gefen Capital, Perot Jain, Dexcel Pharma, Piedmont Capital Investments, Duquesne Family Office, iAngels.